Anticancer Effects of Herbal Medicine Compounds and Novel Formulations: a Literature Review

• Published in: Journal of gastrointestinal cancer 2020-09, Vol.51 (3), p.765-773
• Main Authors: Abdulridha, Manal Khalid, Al-Marzoqi, Ali H., Al-awsi, Ghaidaa Raheem Lateef, Mubarak, Shaden M. H., Heidarifard, Maryam, Ghasemian, Abdolmajid
• Format: Article
• Language: English
• Subjects: Antineoplastic Agents, Phytogenic - pharmacology; Antineoplastic Agents, Phytogenic - therapeutic use; Apoptosis - drug effects; Cancer Research; Cell Cycle Checkpoints - drug effects; Cell Line, Tumor; Cell Proliferation - drug effects; Drug Carriers - chemistry; Gastroenterology; Gene Expression Regulation, Neoplastic - drug effects; Humans; Internal Medicine; Medicine; Medicine & Public Health; MicroRNAs - metabolism; Nanoparticles - chemistry; Neoplasms - drug therapy; Neoplasms - genetics; Neoplasms - pathology; Oncology; Phytotherapy - methods; Plant Preparations - pharmacology; Plant Preparations - therapeutic use; Radiotherapy; Review Article; Signal Transduction - drug effects
• ISSN: 1941-6628; 1941-6636
• DOI: 10.1007/s12029-020-00385-0

Introduction Many agents disrupt the cell cycle and its signaling circuits leading to cancer progress. Cancer therapy is performed by surgery, radiation, and chemical drugs remaining some side effects. Objective To evaluate the anticancer traits of herbal medicines. Methods We collected previously published data in searching engines (Web of Science, PubMed, Medline, and SCOPUS) by searching key words “herbal medicine,” “anticancer effect,” “compounds,” and “fractions.” Results Herbal medicines have unraveled anticancer effects mostly through cancer cells apoptosis via blocking NF-κB pathway by curcumin and terpenoides; CD95 signaling and enhancement of CD95L expression by resveratrol; and inhibiting tyrosine kinas, angiogenesis, and cell cycle arrest in G2/M phase by β-lapachone-genistein and cytochrome-c release into the cytosol and caspase-9 activation by biocalein and quercetin. Additionally, impeding cell cycle in the G1 phase in ovarian cancer cells by 7-hydroxystaurosporine, immune cells enrichment (neutrophils and NK cells activation by Viscum album L., T cells and NK cells activation and cytokines such as tumor necrosis factor release by Ganoderma lucidum and microRNAs regulation (by Sinomeniumacutum, shikonin, Oleaeuropaea, curcumin and ginseng). These effects have implications for proper cancer cells elimination. It has been revealed that cytotoxic effects of herbal compounds (mostly those secondary metabolites) have exerted anticancer properties against several cancer cell lines. In addition, targeting microRNAs, nanoparticle-assisted herbal synergism, and novel drug delivery systems and combination chemotherapies have also emerged exerting higher efficacies for specific cell targeting as novel cancer therapy approaches. Conclusion Considering side effects, toxicity, and higher costs of common cancer therapy approaches, application of novel herbal medicine-based therapies will confer promising insights for health outcomes.